Pharmacy teams identify patients with ‘red-flag’ cancer symptoms in early diagnosis project
Exclusive: Of those identified, 17 people presenting with red-flag symptoms received a formal consultation with a pharmacist during the six-month project.
The proof-of-concept study was delivered by the North Cancer Alliance — a group of six health boards in northern Scotland designed to improve cancer outcomes
Shutterstock.com
Eighteen people with ‘red-flag’ symptoms for lung cancer were identified during a six-month community pharmacy project designed to help early diagnosis.
Get unlimited access to all content
You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
